Back

ECG abnormalities predict 30-day mortality in 10,890 patients with pulmonary embolism

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary embolism: assessment and outcomes Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Joachim Baech

Aalborg University Hospital, Aalborg (Denmark)

5 More presentations in this session

Presentation thumbnail
Refining risk stratification in pulmonary embolism: integrating glomerular filtration rate and simplified pulmonary embolism severity index as a potent predictor of patient survival
Associate Professor S. Salinger (Nis, RS)
Abstract Slides Video
Presentation thumbnail
TELOS-plus identifies normotensive patients with pulmonary embolism at high risk (>10%) of 30-day mortality
Doctor G. Fabiani (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Redefining treatment paradigms for patients with acute pulmonary embolism and patent foramen ovale
Doctor L. Hobohm (Mainz, DE)
Abstract Slides
Presentation thumbnail
Trends in pulmonary embolism and atrial fibrillation-related mortality in adult US population: a CDC WONDER analysis from 1999 to 2020
Miss O. Dairo (London, GB)
Abstract Slides
Presentation thumbnail
Major bleeding in patients with acute pulmonary embolism: results from the COPE study
Professor C. Becattini (Perugia, IT)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary embolism: assessment and outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Refining risk stratification in pulmonary embolism: integrating glomerular filtration rate and simplified pulmonary embolism severity index as a potent predictor of patient survival
thumbnail
Congress Presentation
High-sensitivity troponin-t concentrations and early risk of myocardial infarction in patients with acute pulmonary embolism
thumbnail
Congress Presentation
TELOS-plus identifies normotensive patients with pulmonary embolism at high risk (>10%) of 30-day mortality

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources